Value Comes To Pharmaceuticals, Devices & Digital Treatment

Last month Geisinger, a Pennsylvania-based health system and health plan, announced plans to expand its ProvenCare Total Hip program with Medacta International, by launching a pilot that will cover consumers' lifetime costs of any subsequent hip replacement surgery (see Geisinger Launches 'Guaranteed For Life' Hip Replacement Pilot Program Through Partnership With Medacta). The initiative is an example of the evolution and operationalization of the concept of "value" in the health care system. The unique twist in this program is the involvement of a device manufacturer as a partner. Francesco Siccardi, executive vice president of Medacta International, made a very . . .